A stark contrast in the pricing of the diabetes drug Ozempic has reignited debate over the cost of pharmaceutical goods in the United States. Canadian patients are paying significantly less for the same medication, a discrepancy that has drawn attention to the UK’s healthcare model as a potential benchmark for reform.
Data from the Canadian Institute for Health Information shows that a month’s supply of Ozempic costs approximately $150 in Canada, compared to over $900 in the United States. The price difference is attributed to Canada’s single-payer system, which negotiates drug prices directly with manufacturers. In the absence of such mechanisms, US patients face some of the highest drug costs in the developed world.
The UK’s National Health Service, which employs similar price negotiations, has been cited by health economists as a model for managing expenditure without compromising access. “The UK system demonstrates that it is possible to secure lower prices while maintaining high standards of care,” said Dr. Eleanor Grant, a health policy analyst at the London School of Economics. “The US remains an outlier in its reluctance to adopt collective bargaining.”
The disparity has prompted calls from US lawmakers for legislative changes. Senator Bernie Sanders (I-Vermont) has introduced a bill to allow Medicare to negotiate drug prices, a move that echoes the British approach. “The American people are tired of paying the highest prices in the world for prescription drugs,” Sanders said in a statement. “It is time to follow the example of countries like Canada and the United Kingdom.”
Pharmaceutical companies defend their pricing strategies, citing research and development costs. However, critics argue that profits are prioritised over public health. The debate coincides with broader scrutiny of the US healthcare system, which spends 17% of GDP on medical care, compared to 10% in the UK.
The emotional weight of the issue is evident in the stories of patients forced to ration medication due to cost. Ellen Carter, a 62-year-old from Ohio, said she has cut her Ozempic dose in half to save money. “It’s a choice between paying for food or paying for medicine,” she told the New York Times. “In Canada, they don’t have to make that choice.”
